Group A Streptococcus Vaccine Targeting the Erythrogenic Toxins SpeA and SpeB Is Safe and Immunogenic in Rabbits and Does Not Induce Antibodies Associated with Autoimmunity
Group A streptococcus (GAS) is a global pathogen associated with significant morbidity and mortality for which there is currently no licensed vaccine. Vaccine development has been slow, mostly due to safety concerns regarding streptococcal antigens associated with autoimmunity and related complicati...
Main Authors: | Matthew J. Troese, Elodie Burlet, Madeleine W. Cunningham, Kathy Alvarez, Rebecca Bentley, Nissy Thomas, Shanna Carwell, Garry L. Morefield |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/9/1504 |
Similar Items
-
Neutrophil-derived reactive agents induce a transient SpeB negative phenotype in Streptococcus pyogenes
by: Patience Shumba, et al.
Published: (2023-07-01) -
Deletion of the L-Lactate Dehydrogenase Gene ldh in Streptococcus pyogenes Leads to a Loss of SpeB Activity and a Hypovirulent Phenotype
by: Sonja Oehmcke-Hecht, et al.
Published: (2017-09-01) -
RopB-regulated SpeB cysteine protease degrades extracellular vesicles-associated streptolysin O and bacterial proteins from group A Streptococcus
by: Chuan Chiang-Ni, et al.
Published: (2023-12-01) -
Repression of Rgg but not upregulation of LacD.1 in emm1-type covS mutant mediates the SpeB repression in group A Streptococcus
by: Chuan Chiang-Ni, et al.
Published: (2016-11-01) -
Evaluation of emm gene types, toxin gene profiles and clonal relatedness of group A streptococci
by: Firat Zafer Mengeloglu, et al.
Published: (2013-08-01)